Chemel

ChemT Biotechnology is a Singapore-based biotech company that develops an artificial intelligence-enabled virtual cell engineering platform designed to optimize biologics manufacturing. By combining proprietary AI models with small molecule discovery, the company enhances the performance of therapeutic cell types, including T cells and Chinese Hamster Ovary (CHO) cells. Their technology aims to increase production yield and quality while reducing reliance on traditional, costly components. ChemT's platform enables research institutions and pharmaceutical companies to produce advanced biologics, such as antibodies, mRNA, and cell therapies, with greater efficiency and reliability.